ADMA Biologics Inc (NAS:ADMA)
$ 17.67 0.26 (1.49%) Market Cap: 4.12 Bil Enterprise Value: 4.14 Bil PE Ratio: 62.18 PB Ratio: 17.75 GF Score: 68/100

ADMA Biologics Inc at Jefferies Virtual Plasma Summit Transcript

Mar 11, 2021 / 04:20PM GMT
Release Date Price: $2.16 (+1.89%)
Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst

Welcome everyone to the Jefferies First Annual Global Plasma Summit. With us up next, we have Adam Grossman and Brian Lenz, CEO and CFO of ADMA Biologics. We have 30 minutes allotted for a fireside chat session. So we look forward to the segment, and thank you both for joining us this year.

Brian Lenz
ADMA Biologics, Inc. - Executive VP & CFO

Thank you for having us.

Adam S. Grossman
ADMA Biologics, Inc. - Co-Founder, President, CEO & Director

Thank you very much, Anthony.

Questions & Answers

Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst

And maybe where we're starting off, Adam, is a little bit on a look back at 2020 and where we sit as of March, mid-March now we're approaching, it is the 1-year anniversary for most of COVID-19. So maybe a moment on how 2020 played out for ADMA and what are the most updated views as we sit here at the 1-year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot